English Oral Session

English Oral Session 2

Sat. Jul 6, 2019 10:15 AM - 10:55 AM Room 4 (3F/301)

Chairs: Fumitaka Kikkawa, Keiichi Fujiwara

+Add all to schedule

[IS-005] Prolactin Enhances the Proliferation of Endometrial Glandular Cells and Endometrial Cancer Cells via Regulation of Prolactin Receptor and Estrogen Receptor

Munekage Yamaguchi¹, Fumitaka Saito¹, Ritsuo Honda¹, Takashi Ohba¹, Hironori Tashiro², Hidetaka Katabuchi¹ (1.Department of Obstetrics and Gynecolgy, Faculty of Life Sciences, Kumamoto University, 2.Department of Mother-Child Nursing, Faculty of Life Sciences, Kumamoto University)

[IS-006] Clinicopathologic Characteristics Associated with Progression-free and Overall Survival of Stage IVb Uterine Endometrial Cancer Patients

Takaya Shiozaki, Mamiko Oota, Hajime Uda, Kyoko Shimada, Kazuhiro Suzuki, Takashi Shibutani, Kasumi Yamamoto, Noriatsu Jimi, Hiroko Yano, Miho Kitai, Kazuko Matsuoka, Syoji Nagao, Satoshi Yamaguchi (Department of Gynecology, Hyogo Cancer Center)

[IS-007] Feasibility of Initial Treatment in Elderly Patients with Ovarian Cancer in Japan: A Retrospective Study

Mayu Yunokawa^1,2, Seiko Bun³, Tomoyasu Kato⁴ (1.Cancer Insititute Hospital of JFCR, Gynecology and Medical Oncology, 2.National Cancer Center Hospital, Breast and Medical Oncology, 3.National Center for Child Health and Development Hospital, Department of Pharmacy, 4.National Cancer Center Hospital, Gynecology)

[IS-008] The Development of a Novel MicroRNA Replacement Therapy for Ovarian Cancer with Patient Derived-exosomes as a Carrier

Masaki Kobayashi, Kenjiro Sawada, Aasa Shimizu, Mayuko Miyamoto, Akihiko Yoshimura, Koji Nakamura, Tadashi Kimura (Osaka University)

[IS-009] BET Protein Inhibition in Combination with PI3K-AKT Signal Inhibitors as a Therapeutic Strategy for Clear Cell Carcinoma of the Ovary

Shogo Shigeta^1,2, Carla Grandori³, Christopher Kemp² (1.Department of Obstetrics and Gynecology, Tohoku University School of Medicine, 2.Fred Hutchinson Cancer Research Center, 3.SEngine Precision Medicine)

Session information